| Tag | Content |
|---|
EnhancerAtlas ID | HS029-05579 |
Organism | Homo sapiens |
Tissue/cell | CUTLL1 |
Coordinate | chr16:28934860-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TCTATTTAAA GAACAAATAT TAAGTAAACA GCACAGTAAG TTGTACAAGG ATGTGTCTAC 60
ATTGCACAGG CAGGTGGATC CTGAAATGTG GGAAATACAG CCCCAGAGAA GTCTCCAGCC 120
ACCAGCAGCT GTTAGAAAGG GAAATCGCAT GTTGGGAAGG GAATTTTAGG AAGTTTACTC 180
TGGAAGCCAA TGTCAAGGCC ACACTATAGA GGAAGATCTG TGAGAAGGTT GGGACAAAAG 240
TCCAGGAGAG AGTTGACGAG AGCCCCACCG CAGCAGGGGC ATAGCAGCGG GGGCAGCTCT 300
GACATCTGTT TCAGAGTCTC TGGCTTCTGC TAGAGGAAGG AGAGTAGAAA ACAGGATCAG 360
CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA CGTGGGGCGG AGGTGGGGAA 420
GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG AAGGCTAGAG AGCAGAGCAT 480
TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC AGAAGTCCAG ACTAAAATGA 540
GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA GGGTTGATCA ATCATCAGTG 600
AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG CTGGGAGCTA AACTTAGCTA 660
TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT GCAAATTTTA AAAGGGCGGC 720
CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC CTGCTAACCT ATCCCATAGC 780
TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC AGTATGGGGT TGATGGGGAG 840
TCTAGGTGAG TCCCGCGTCT 860
|
